First, targeting or knocking-out TSPO by synthesizing the ligand XBD173 confirmed that TSPO could inhibit phagocytic reactivity in the laser-induced mouse neovascular age-related macular degeneration model. Here, TSPO is linked to age-related macular degeneration.